(Q35605057)

9 August 2017

1 reference

title

Use of progestins in male contraception (English)

1 reference

9 August 2017

1 reference

1

Eberhard Nieschlag

1 reference

9 August 2017

Michael Zitzmann

2

1 reference

9 August 2017

Axel Kamischke

series ordinal

3

1 reference

9 August 2017

publication date

1 November 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

68

1 reference

9 August 2017

issue

10-13

1 reference

9 August 2017

page(s)

965-972

1 reference

Contraceptive efficacy of testosterone-induced azoospermia in normal men

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Reversible azoospermia induced by the anabolic steroid 19-nortestosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Suppression of spermatogenesis to azoospermia by combined administration of GnRH antagonist and 19-nortestosterone cannot be maintained by this non-aromatizable androgen alone

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Can testosterone alone maintain the gonadotrophin-releasing hormone antagonist-induced suppression of spermatogenesis in the non-human primate?

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Clinical trial of 19-nortestosterone-hexoxyphenylpropionate (Anadur) for male fertility regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Effects of testosterone plus medroxyprogesterone acetate on semen quality, reproductive hormones, and germ cell populations in normal young men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Clinical Trial of Transdermal Testosterone and Oral Levonorgestrel for Male Contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Combination of subcutaneous levonorgestrel implants and transdermal dihydrotestosterone gel for male hormonal contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Intramuscular testosterone undecanoate with or without oral levonorgestrel: a randomized placebo-controlled feasibility study for male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Steroids. LIV.1Synthesis of 19-Nov-17α-ethynyltestosterone and 19-Nor-17α-methyltestosterone2

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Inhibition of spermatogenesis in men using various combinations of oral progestagens and percutaneous or oral androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

The effects of low doses of cyproterone acetate on some functions of the reproductive system in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Medium dose cyproterone acetate (CPA): effects on hormone secretion and on spermatogenesis in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Use of low-dosage oral cyproterone acetate as a male contraceptive.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Low dose of cyproterone acetate and testosterone enanthate for contraception in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

An oral regimen of cyproterone acetate and testosterone undecanoate for spermatogenic suppression in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Oral progestogen combined with testosterone as a potential male contraceptive: additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Oral desogestrel with testosterone pellets induces consistent suppression of spermatogenesis to azoospermia in both Caucasian and Chinese men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Twenty-one day administration of dienogest reversibly suppresses gonadotropins and testosterone in normal men.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Testosterone-induced inhibition of spermatogenesis is more closely related to suppression of FSH than to testicular androgen levels in the cynomolgus monkey model (Macaca fascicularis).

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Establishing the minimum effective dose and additive effects of depot progestin in suppression of human spermatogenesis by a testosterone depot.

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

Role of FSH in the regulation of spermatogenesis: clinical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

CAG repeat length in the androgen receptor gene and gonadotrophin suppression influence the effectiveness of hormonal male contraception

1 reference

https://api.crossref.org/works/10.1016%2FS0039-128X%2803%2900135-1

7 January 2021

10.1016/S0039-128X(03)00135-1

Identifiers

DOI

1 reference

9 August 2017

1 reference